about
Stent thrombosis is the primary cause of ST-segment elevation myocardial infarction following coronary stent implantation: a five year follow-up of the SORT OUT II study.Effect of early revascularisation in cardiogenic shock complicating acute myocardial infarction. A single center experience.Predictors and prognostic value of left atrial remodelling after acute myocardial infarction.Assessment of rheumatic mitral valve disease. Value of echocardiography in patients clinically suspected of predominant stenosisCardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance.Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial.Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.Echocardiographic Assessment of Regional and Global Left Ventricular Function Wall-Motion Scoring in Parasternal and Apical Views Versus Apical Views Alone.Effect of the imidazoline-derivative ST-91 on heart rate and blood pressure in healthy man.The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial.Percutaneous treatment of coronary bifurcation lesions: a novel "extended Y" technique with complete lesion stent coverage.Systemic drugs for restenosis prevention: old idea, new drugs.Efficiency and safety of the sirolimus eluting stent in complex coronary artery lesions after cessation of dual antiplatelet therapy: fifteen months clinical outcome of the randomised Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSirolimus-eluting versus bare-metal stent implantation in patients with ostial lesions.[Total atrioventricular block in acute myocardial infarct]Pre-discharge exercise test for evaluation of patients with complete or incomplete revascularization following primary percutaneous coronary intervention: a DANAMI-2 sub-study.Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to "mega centre" for patients with ST-segment elevation myocardial infarction.[Hospital prognosis for acute myocardial infarct at different stages of the development of the coronary care unit. Experiences from the introduction of full-term monitoring by telemetry and the abolishment of the coronary regimen]Target vessel revascularization following percutaneous coronary intervention. A 10-year report from the Danish Percutaneous Transluminal Coronary Angioplasty Registry.Between observer variation is not eliminated by standardised analysis of dobutamine-atropine stress echocardiography.Quantitative analysis of dobutamine-atropine stress echocardiography by fractional area change.Quantitative analysis of dobutamine-atropine stress echocardiography.Percutaneous revascularization in acute myocardial infarction due to left main stem occlusion.7,528 patients treated with PCI--a Scandinavian real-life scenario.Long-term prognosis in an ST-segment elevation myocardial infarction population treated with routine primary percutaneous coronary intervention: from clinical trial to real-life experience.Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial InfHypercoagulation assessed by thromboelastography is neither related to infarct size nor to clinical outcome after primary percutaneous coronary intervention.Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial.Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study.Impact of acute hyperglycemia on myocardial infarct size, area at risk, and salvage in patients with STEMI and the association with exenatide treatment: results from a randomized study.A comprehensive estimation of acute myocardial infarct size using enzymatic, electrocardiographic and mechanical methods.Restenosis in coronary bare metal stents. Importance of time to follow-up: a comparison of coronary angiograms 6 months and 4 years after implantation.Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study.Impact of system delay on infarct size, myocardial salvage index, and left ventricular function in patients with ST-segment elevation myocardial infarction.ST peak during primary percutaneous coronary intervention predicts final infarct size, left ventricular function, and clinical outcome.Comparison of Selvester QRS score with magnetic resonance imaging measured infarct size in patients with ST elevation myocardial infarction.Effect of intravenous streptokinase on the relation between initial ST-predicted size and final QRS-estimated size of acute myocardial infarcts.Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial.How should I treat subacute stent thrombosis in the context of brain haemorrhage with abciximab?Short- and long-term cause of death in patients treated with primary PCI for STEMI.
P50
Q34542615-47E3364E-0321-4229-B854-272EAC0387F2Q35057078-08123DF8-78A7-45D6-917B-593A3CEC1A91Q35722052-028FABB7-A18E-4CE1-8494-5045BE547E93Q36854592-0D34411C-D7BE-456D-87CC-0A439E647D01Q38376053-C0C77FC9-CAC6-4CE7-805F-4ED5FAD6350AQ38380111-39030CA8-4EEE-4464-A3ED-97A8580AFE9FQ38392662-53AA5C90-990A-4A67-890C-DB92660E6653Q39557440-EECEDE5E-4069-4ABC-A66C-4DC4AD174489Q41870896-F2014DDD-1ED6-42F8-9577-F6B7B8E3165EQ42166834-4E289283-6527-4D46-BFC9-281D55B278C6Q42833423-7868E5FB-FBA0-47D7-B143-436056DD0B94Q43249040-7EDC9F33-C97B-4918-9C45-A1DCC84D97E3Q43279556-4C0D590C-611B-49CB-B43F-A461CFF81879Q43283909-0B31A832-BE80-4803-A380-6750A133AC95Q43490566-08DDACB8-0FAA-422C-A8A4-4706BA28AD31Q43533190-103168C9-E5E2-428F-B9D9-3BE6FD37058FQ43585011-44F770A7-FF6F-48EF-BEE5-AEBDED6E37EAQ43780143-09E3C86C-7DB8-495A-82D9-7B17D71C6700Q43862116-D00B07A6-074A-4DA6-9E52-235617AFC626Q44067863-CE1607E0-4F7D-471F-9053-9D84EAA21545Q44080723-825936F9-4627-45B4-924A-AB0C471E7A92Q44555787-384AA595-8E29-40A7-B136-AE9C71BC2758Q44674447-2E0BE77C-F44B-4A44-9A03-ED140E27E63CQ44892384-232FABA3-F44F-4A76-83E4-45827A791486Q44936828-D4BAE2F5-4C38-4C57-B6AB-8843021B8AACQ45911756-E2CACB42-AFAE-4958-9EB4-49E32C933F83Q46472467-82AD52F8-9C45-4F15-8D6C-41DE49C87A0EQ46579604-F133044D-6ABB-4CAC-B8A7-1B61A625AAA0Q46858489-9A52F475-DD09-481E-B2D0-344182DA380CQ47180985-36FABA3D-98B4-4CA8-8979-75F5CEAA89FAQ47195186-36D190E4-278A-4BA8-A55D-DE4164570DADQ47217489-A650755B-2AC7-4452-AB22-93BFE6FDBD77Q47270854-48042354-4CD3-4027-9234-FD0D16BFFF4AQ47279046-534E7ED5-5C27-4239-B95A-3670F9886DD6Q47295477-65AFB180-AED5-4D63-9450-D09B3E343DE5Q47312235-83CCF091-AB81-42BF-9025-2FC97CD11D55Q47440113-5D14D51C-6425-48E8-AFFA-935B1719D860Q47880176-A8731B3A-714D-4071-8523-8C92CF073B25Q48318305-0C748564-70AC-4F0C-AF07-7BBE9BE8AB53Q48431119-A8D7AF89-713C-41B9-8C01-F277437BA1D9
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kari Saunamaki
@ast
Kari Saunamaki
@en
Kari Saunamaki
@es
Kari Saunamaki
@nl
Kari Saunamaki
@sl
type
label
Kari Saunamaki
@ast
Kari Saunamaki
@en
Kari Saunamaki
@es
Kari Saunamaki
@nl
Kari Saunamaki
@sl
prefLabel
Kari Saunamaki
@ast
Kari Saunamaki
@en
Kari Saunamaki
@es
Kari Saunamaki
@nl
Kari Saunamaki
@sl
P106
P21
P31
P496
0000-0001-5953-5243